PNTG
Premium GrowerThe Pennant Group, Inc. · Healthcare · United States · $1.5B cap · $14.7M/day traded
$35.91 -2.4% · close 12 Nov · scored 13 Nov
Score down 1.7 since 12 Nov.
Premium Grower: Strong business with the market behind it, priced at a premium.
After its 4 Nov results, analysts left next year's EPS estimate little changed.
As of 13 Nov 2026, the MoatMap Score for The Pennant Group, Inc. (PNTG) is 54/100, ranked against 25,000+ stocks in 38 markets (Quality 52, Value 36, Momentum 61, each scored against its sector).
Does the score work? Each tenth of the ranking, tracked monthly. See the record →
ABOUT THE PENNANT GROUP, INC.
Read
The Pennant Group, Inc. is a healthcare services company operating home health, hospice, and senior living facilities across multiple states. The company's competitive edge is its localized, de-centralized operating model that empowers local leaders to tailor services to their communities, fostering strong relationships and high-quality care. It is a growing player in the post-acute and senior care markets.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 473.2M | 544.9M | 695.2M | 947.7M | 26.0% | 1.2B | 1.2B | 1.3B | 16.1% |
| EPS | 0.23 | 0.45 | 0.72 | 0.86 | 55.2% | 1.01 | 1.02 | 1.16 | 16.0% |
| Shares | 29.7M | 29.9M | 34.4M | 34.6M | +16.6% | 35.1M | — | — | — |
| Debt | 326.6M | 329.6M | 273.1M | 453.2M | 11.5% | 488.9M | — | — | — |
| Equity | 121.0M | 140.3M | 293.3M | 332.6M | 40.1% | — | — | — | — |
| Op CF | 9.0M | 33.1M | 39.3M | 48.3M | 74.8% | 64.5M | — | — | — |
| Inv CF | -24.2M | -30.2M | -70.7M | -228.0M | — | — | — | — | — |
| Fin CF | 12.1M | 1.1M | 49.6M | 172.5M | — | — | — | — | — |
No clear trend: not near its 52-week low, and not in a steady uptrend.
Calmer than 55% of stocks we rank over the past year (volatility 39% a year).
How this is worked out
The Price check reads only the chart, the price side of the Momentum score in words; it is not the MoatMap Score.
- Still falling: It set a new 52-week low in the last two weeks, after a deep fall.
- Finding a floor: It fell hard, but has set no new low for more than two weeks.
- Turning up: It has climbed off its low and is back above a rising 50-day average.
- In an uptrend: It is near its 52-week high and above its 200-day average.
- No clear trend (this stock): None of the above: no recent deep fall and no steady climb.
- No read yet: Not enough price history yet: it needs a year of trading.
In past US falls, waiting for Turning up cut the chance of another 20% drop from 42% to 33%. Returns were no better, and 33% of turns failed.
The exact rules
Still falling is a new 52-week low in the last two weeks, at least 25% below the high, with the low set after the high. Finding a floor is the same fall with no new low in the last two weeks. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average, with the 50-day average above the 200-day, and within 15% of the high. No clear trend is everything else. No read yet is under 252 trading days of history, or missing data. A new state shows once it has held for three trading days.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: how much the price moved day to day over the past year, scaled to a yearly figure (annualised volatility) and ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PNTG are excluded.
| Ticker | Company | Mkt Cap | Score |
|---|---|---|---|
| PNTG | The Pennant Group, Inc.(you) | $1.5B | 54 |
| AGL | agilon health, inc. | $1.5B | 42 |
| USPH | U.S. Physical Therapy, Inc. | $1.3B | 65 |
| ASTH | Astrana Health, Inc. | $1.9B | 65 |
| SGRY | Surgery Partners, Inc. | $2.1B | 64 |
| INNV | InnovAge Holding Corp. | $1.3B | 77 |
| SNDA | Sonida Senior Living, Inc. | $1.6B | 30 |
| ACHC | Acadia Healthcare Company, Inc. | $2.9B | 68 |
| SRTA | Strata Critical Medical, Inc. | $412M | 45 |
| CYH | Community Health Systems, Inc. | $412M | 63 |
Peer medians: ROE -31.0% · P/E 25.7x · Gross margin 63.3%
Company Deep Dive
A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.